MC-betaglucuronide-MMAE-1 is part of an antibody-drug conjugate consisting of tubulin polymerization inhibitor MMAE and degradable ADC linker MC-betaglucuronide.
Catalog Number | Size | Price | Quantity | |
---|---|---|---|---|
BADC-01459 | -- | $-- | Inquiry |
MC-betaglucuronide-MMAE-1, a cutting-edge targeted therapeutic agent tailored for precision oncology and diverse biomedical applications, boasts remarkable efficacy.
Cancer Therapy: Standing as a formidable anti-cancer powerhouse, MC-betaglucuronide-MMAE-1 operates through a precision-targeted delivery mechanism. This agent is intricately conjugated to an antibody engineered to home in on tumor-associated antigens, facilitating the precise transportation of the cytotoxic MMAE payload to malignant cells. By honing in on cancer cells with pinpoint accuracy, this targeted therapy not only minimizes collateral damage to healthy tissues but also amplifies the treatment's effectiveness across various cancer subtypes.
Antibody-Drug Conjugates (ADCs): Spearheading the realm of cancer therapeutics, MC-betaglucuronide-MMAE-1 takes center stage as a pivotal component in ADCs—a groundbreaking approach in cancer treatment. By integrating the glucuronide-MMAE conjugate with antibodies or peptides exhibiting high specificity towards cancer markers, these ADCs orchestrate the direct delivery of lethal toxins exclusively to cancerous cells.
Pharmacokinetic and Toxicity Studies: Driving forward preclinical and clinical investigations, MC-betaglucuronide-MMAE-1 serves as a cornerstone in evaluating drug metabolism, pharmacokinetics, and toxicity profiles within novel therapeutic paradigms. These meticulous studies play a pivotal role in determining optimal dosing strategies, unraveling potential side effects, and identifying toxicities that could emerge. A deep comprehension of these profiles is paramount for the secure and efficacious integration of this therapeutic agent into clinical environments, ensuring patient safety and treatment success.
Customer Support
Providing excellent 24/7 customer service and support
Project Management
Offering 100% high-quality services at all stages
Quality Assurance
Ensuring the quality and reliability of products or services
Global Delivery
Ensuring timely delivery of products worldwide
BOC Sciences offers comprehensive services for ADC manufacturing, including antibody modification, linker chemistry, payload conjugation, and formulation development. In particular, our payload-linker customization service offers a convenient and fast raw material channel for many ADC researchers.
BOC Sciences provides one-stop site-specific conjugation services for amino acids, glycans, unnatural amino acids, and short peptide tags. In addition, cysteine conjugation, lysine conjugation, enzymatic conjugation, thio-engineered antibody can also be obtained quickly.
BOC Sciences offers a full range of linkers, including peptide linkers, PEG linkers, click chemistry, PROTAC linkers, non-cleavable linkers, etc. We also provide custom development services for chemically labile linkers and enzymatically cleavable linkers.